The Food and Drug Administration (FDA) announced the following public workshop entitled “Next Generation Sequencing-Based Oncology Panels.” The purpose of this workshop was to obtain feedback on analytical and clinical validation approaches for next generation sequencing (NGS)-based oncology panels. Comments and suggestions generated through this workshop will help guide the development of appropriate regulatory standards for evaluation of NGS-based oncology panels in cancer patient management.
- Date, Time and Location
- Federal Register Notice
- Webcast Archive
- Discussion Paper
- Agenda
- Registration
- Contact Us
FDA Campus Information
Webcast Archive
Discussion Paper for Workshop (PDF – 325KB)
Presentation Slides (PDF – 8.7MB)
[email protected].
For questions regarding workshop content please contact:
Jennifer Dickey, Ph.D., Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave, Bldg. 66 rm. 5648, Silver Spring, MD 20993, 301-796-5028, email: [email protected].
Presentation Slides (PDF – 8.7MB)
[email protected].
For questions regarding workshop content please contact:
Jennifer Dickey, Ph.D., Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave, Bldg. 66 rm. 5648, Silver Spring, MD 20993, 301-796-5028, email: [email protected].
For questions regarding workshop content please contact:
Jennifer Dickey, Ph.D., Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave, Bldg. 66 rm. 5648, Silver Spring, MD 20993, 301-796-5028, email: [email protected].